Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | October 20, 2010 |
| Target | Photocure ASA - Lumacan |
| Sector | Life Science |
| Buyer(s) | Salix Pharmaceuticals |
| Sellers(s) | Photocure ASA |
| Deal Type | Divestiture |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1989 |
| Sector | Life Science |
| Revenue | 933M USD (2013) |
Salix Pharmaceuticals Ltd. is a developer and marketer of prescription pharmaceutical products and medical devices for the prevention and treatment of gastrointestinal diseases. Salix's strategy is to in-license late-stage or marketed proprietary therapeutic products, complete any required development and regulatory submission of these products, and market them through Salix's gastroenterology specialty sales and marketing team.
| Deal Context for Buyer | # |
|---|---|
| Overall | 2 of 4 |
| Sector: Life Science | 1 of 2 |
| Type: Divestiture | 1 of 1 |
| Country: Norway | 1 of 1 |
| Year: 2010 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-06-04 |
Q-Med Scandinavia
Princeton, New Jersey, United States Q-Med Scandinavia, Inc. provides treatment products of vesicoureteral reflux. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-11-08 |
Oceana Therapeutics
Edison, New Jersey, United States Oceana Therapeutics, Inc., a privately-held provider of gastroenterology and urology therapeutics. |
Buy | - |
Photocure, is a providder in photodynamic technology in pharmaceutical company. Today, the company has over 60 employees and operates in Norway, Sweden, Denmark, Finland and the United States.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| Country: Norway | 1 of 1 |
| Year: 2010 | 1 of 1 |
